MENU
CLOSE
Home
News
2018 Announcements
2018 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
CLINUVEL Vitiligo Communiqué
2018 Announcements
.
Newsletter
19.12.2018
CUV103 Singaporean Phase II vitiligo study results
2018 Announcements
19.12.2018
CLINUVEL Newsletter – December 2018
2018 Announcements
17.12.2018
Results of Meeting
2018 Announcements
21.11.2018
Managing Director AGM Presentation
2018 Announcements
21.11.2018
Chair’s Address to the Annual General Meeting
2018 Announcements
20.11.2018
CLINUVEL Newsletter – November 2018
2018 Announcements
05.11.2018
Appendix 4C
2018 Announcements
31.10.2018
CLINUVEL expands Singapore laboratory facilities
2018 Announcements
29.10.2018
Appendix 4G and Corporate Governance Statement
2018 Announcements
18.10.2018
Notice of Annual General Meeting/Proxy Form
2018 Announcements
18.10.2018
Appeal Upheld Against NICE Recommendation in England
2018 Announcements
10.10.2018
Sachs 18th Biotech in Europe Forum Presentation
2018 Announcements
08.10.2018
.
1
2
3
4
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
About Pharmaceuticals
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top